* A Tier 3 biotech stock denotes a company that has approved products and recurring revenues but is not yet profitable.
* They are less risky than Tier 4 (developmental) concerns. This space is where you see a lot of buyouts happen as well.
* Here are three attractive Tier 3 biotech stocks under $10 a share that should have a bright 2017 ahead of them.
